candesartan cilexetil has been researched along with fibrinogen in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujimura, A; Sugimoto, K; Tsuruoka, S | 1 |
Monteduro, C; Muiesan, ML; Porteri, E; Rizzoni, D; Rosei, EA; Salvetti, M; Sleiman, I | 1 |
1 trial(s) available for candesartan cilexetil and fibrinogen
Article | Year |
---|---|
Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Enalapril; Female; Fibrinogen; Humans; Hypertension; Intercellular Adhesion Molecule-1; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Tetrazoles; Vascular Cell Adhesion Molecule-1; von Willebrand Factor | 2005 |
1 other study(ies) available for candesartan cilexetil and fibrinogen
Article | Year |
---|---|
Effect of prolonged nitric oxide synthesis inhibition on plasma fibrinogen concentration in rats.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Disease Models, Animal; Enzyme Inhibitors; Fibrinogen; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Tetrazoles | 2001 |